The Cong lab develops novel technologies at the intersection of genome engineering, single-cell analysis, and computational genomics. They focus on immune-related disease to employ these tools for understanding cancer immunology, neuro-immunology, and mechanistic insights that may lead to transformative diagnostics or therapeutics with tailored genetic/epigenetic approaches.

The Tarpeh Lab develops and evaluates novel approaches to resource recovery from “waste” waters at several synergistic scales: molecular mechanisms of chemical transport and transformation; novel unit processes that increase resource efficiency; and systems-level assessments that identify optimization opportunities.

The Kuo lab studies a group of airway epithelial cells called pulmonary neuroendocrine (NE) cells.  They are normally a rare cell type in the lung with sensory, neurosecretory, and stem cell functions. Some NE cells can be located at branchpoints in highly innervated clusters called neuroepithelial bodies (NEBs), which are abnormal in several pediatric and adult respiratory diseases.  The lab uses single cell genetic approaches to study NE cell development and function.

Dr. He's research is concentrated in the area of statistical genetics and integrative analysis of omics data, attempting to develop new statistical methodologies that aid with the identification and interpretation of complex biological pathways involved in human diseases, particularly neurological disorders.

Dr. Ennis works to develop advanced translational cardiac and cardiovascular MRI methods for quantitatively assessing structure, function, flow, and remodeling in both adult and pediatric populations. He is also the Director of Radiology Research for the Veterans Administration Palo Alto Health Care System, where he oversees a growing radiology research program that brings together researchers and clinicians to tackle pressing clinical problems.

The research focus of Dr. Pasca’s lab is to understand molecular mechanisms underlying neurodevelopmental disorders associated with premature birth and neonatal brain injury with the long-term goal of translating the lab’s findings into therapeutics.

Dr. Williams is the founding Director of the PanLab for Precision Psychiatry and Translational Neuroscience and has developed a radical new way to understand and treat mental disorders, anchored in a neuroscience-informed model for precision mental health.

The Dassama laboratory at Stanford performs research directed at understanding and mitigating bacterial multidrug resistance (MDR). Efforts to combat MDR involve two broad strategies: understanding how resistance is acquired in hopes of mitigating it, and identifying new compounds that could serve as potent antibiotics.

Dr. Wang's group develops technologies for x-ray and CT imaging, using the Zeego Interventional X-Ray Lab and the Tabletop Cone-Beam CT Lab. They welcome collaborations with clinical and engineering teams to advance these technologies into clinical care.

Dr. Gomez-Ospina is a physician scientist and medical geneticist with a strong interest in the diagnosis and management of genetic diseases.